Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Nephrology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Immune Complex-mediated MPGN Secondary to Primary Biliary Cholangitis
5
Mins
July 2024
Immune complex-mediated membranoproliferative glomerulonephritis (iMPGN) can develop in association with autoimmune diseases such as…
Read more
4
Mins
16th February 2024
Membranous Nephropathy and Pulmonary Tuberculosis
Mycobacterium tuberculosis causing glomerulonephritis (GN) is a rare occurrence, and its association has been seldom reported…
10
Mins
14th December 2023
Current Treatment and Emerging Solutions in IgA Nephropathy
IgAN, which can lead to CKD and kidney failure, is the most common form of primary glomerulonephritis, predominantly…
12
Mins
15th August 2023
Diagnosing Fabry Disease: Practical Clinical Recommendations and Guidance for Patients with Fabry Disease
This article was funded by Sanofi and is intended for healthcare professionals.
10
Mins
27th July 2023
Filling the Gap by Targeting the Gut: First Disease-Modifying Treatment Approved for IgA Nephropathy
Bengt Fellström, Uppsala University, Sweden, described the relationship between IgA nephropathy (IgAN) and gastrointestinal mucosal…
5
Mins
27th July 2023
Proteinuria as a Surrogate Endpoint for Disease Progression in IgA Nephropathy: Predicting Long-Term Treatment Effects of Sparsentan
IgA nephropathy (IgAN) is a rare, life-limiting disease for which there is significant unmet need. Until recently, drug development for…
8
Mins
27th July 2023
Interview: Catherine Quinlan
I only ever wanted to be a paediatrician, thanks to ER’s Doug Ross, and my first job was on the nephrology service in Temple Street…
11
Mins
27th July 2023
Recent Advances in Targeting Complement in Glomerular Disease
The complement system has been an appealing drug target for a long time. However, early drug development efforts have failed for…
10
Mins
27th July 2023
The Effect of Tip Placement on Fibrin Sheath Formation in Poorly Functioning Tunnelled Haemodialysis Lines
One of the most common causes of a poorly functioning haemodialysis (HD) line is the formation of a fibrin sheath. Tunnelled HD lines contain a Dacron® (Invista, Wichita, Kansas, USA) cuff at the skin entry site, which helps secure the catheter in place due to the fibrosis that occurs in the subdermal tissues.
Loading posts...
« Previous
1
2
3
4
…
19
Next »